LIEBENS PHARMA: what changed
What changed
LIEBENS PHARMA
NACE 64.210, Activities of holding companies
filed annual accounts (NBB)
Net result for the year
€134,538
2024 · €105,655+€28,883
Equity
€219,610
2024 · €285,072-€65,462
Cash
€72,065
2024 · €75,983-€3,917
Balance sheet total
€1.0m
2024 · €1.0m+€41,805
Largest movements
Assets
- Receivables within one year +€46,410
up €46,410 (+51.1%), from €90,856 to €137,266
of which Other amounts receivable: +€46,410
Equity and liabilities
- Other debts +€148,597
up €148,597 (+583%), from €25,500 to €174,097
- Reserves -€65,462
down €65,462 (-24.6%), from €266,472 to €201,010
- Debts after one year -€45,135
down €45,135 (-7.2%), from €628,719 to €583,584
Income statement
- Gross operating margin +€37,859
up €37,859 (+24.0%), from €158,059 to €195,918
- Taxes +€9,486
up €9,486 (+31.3%), from €30,272 to €39,758
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€105,655
Gross operating margin
+€37,859
Depreciation
+€324
Other operating charges
+€115
Other operating items
-€972
Financial income
-€17
Financial charges
+€1,059
Taxes
-€9,486
Result 2025
€134,538
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€231,867
Investment
+€972
Financing
-€236,757
Cash 2024
€75,983
From operations (derived)
+€231,867
Net result for the year
+€134,538
Receivables within one year
-€46,410
Smaller working-capital items
-€378
Tax, wage and social debts
-€3,693
Other debts
+€148,597
Accrued charges and deferred income
-€786
Investment (derived)
+€972
Investment in fixed assets (net)
+€972
Financing
-€236,757
Debts after one year
-€45,135
Current portion of long-term debt
+€1,236
Short-term financial debts
+€7,142
Contributions, distributions and other
-€200,000
Cash 2025
€72,065
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,003,718 | €1,045,524 | +€41,805 | +4.2% |
| Fixed assets | 21/28 | €836,157 | €835,184 | -€972 | -0.1% |
| Tangible fixed assets | 22/27 | €972 | €0 | -€972 | -100% |
| Plant, machinery and equipment | 23 | €972 | €0 | -€972 | -100% |
| Financial fixed assets | 28 | €835,184 | €835,184 | = | 0.0% |
| Current assets | 29/58 | €167,561 | €210,339 | +€42,778 | +25.5% |
| Amounts receivable within one year | 40/41 | €90,856 | €137,266 | +€46,410 | +51.1% |
| Trade receivables | 40 | €0 | - | = | |
| Other amounts receivable | 41 | €90,856 | €137,266 | +€46,410 | +51.1% |
| Cash at bank and in hand | 54/58 | €75,983 | €72,065 | -€3,917 | -5.2% |
| Deferred charges and accrued income | 490/1 | €723 | €1,008 | +€285 | +39.4% |
| Total equity and liabilities | 10/49 | €1,003,718 | €1,045,524 | +€41,805 | +4.2% |
| Equity | 10/15 | €285,072 | €219,610 | -€65,462 | -23.0% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €266,472 | €201,010 | -€65,462 | -24.6% |
| Distributable reserves | 133 | €266,472 | €201,010 | -€65,462 | -24.6% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €718,646 | €825,913 | +€107,267 | +14.9% |
| Amounts payable after more than one year | 17 | €628,719 | €583,584 | -€45,135 | -7.2% |
| Financial debts | 170/4 | €628,719 | €583,584 | -€45,135 | -7.2% |
| Amounts payable within one year | 42/48 | €89,141 | €242,329 | +€153,188 | +172% |
| Current portion of amounts payable after more than one year | 42 | €43,899 | €45,135 | +€1,236 | +2.8% |
| Financial debts | 43 | €6,348 | €13,490 | +€7,142 | +113% |
| Credit institutions | 430/8 | €6,348 | €13,490 | +€7,142 | +113% |
| Trade debts | 44 | €860 | €767 | -€93 | -10.9% |
| Suppliers | 440/4 | €860 | €767 | -€93 | -10.9% |
| Taxes, remuneration and social security | 45 | €12,534 | €8,840 | -€3,693 | -29.5% |
| Taxes | 450/3 | €12,534 | €8,840 | -€3,693 | -29.5% |
| Other amounts payable | 47/48 | €25,500 | €174,097 | +€148,597 | +583% |
| Accrued charges and deferred income | 492/3 | €786 | €0 | -€786 | -100% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €324 | €0 | -€324 | -100% |
| Other operating charges | 640/8 | €1,834 | €1,719 | -€115 | -6.2% |
| Non-recurring operating charges | 66A | - | €972 | +€972 | |
| Gross operating margin | 9900 | €158,059 | €195,918 | +€37,859 | +24.0% |
| Operating profit (loss) | 9901 | €155,901 | €193,227 | +€37,326 | +23.9% |
| Financial income | 75/76B | €17 | €0 | -€17 | -100% |
| Recurring financial income | 75 | €17 | €0 | -€17 | -100% |
| Financial charges | 65/66B | €19,990 | €18,931 | -€1,059 | -5.3% |
| Recurring financial charges | 65 | €19,990 | €18,931 | -€1,059 | -5.3% |
| Profit (loss) for the period before taxes | 9903 | €135,928 | €174,296 | +€38,368 | +28.2% |
| Income taxes | 67/77 | €30,272 | €39,758 | +€9,486 | +31.3% |
| Profit (loss) for the period | 9904 | €105,655 | €134,538 | +€28,883 | +27.3% |
| Profit (loss) for the period to be appropriated | 9905 | €105,655 | €134,538 | +€28,883 | +27.3% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 8 November 2026 via checked.be.